{"id":"https://openalex.org/W2011735384","doi":"https://doi.org/10.4161/cbt.9.9.11441","title":"Dose/dense metronomic chemotherapy with fractioned cisplatin and oral daily etoposide enhances the anti-angiogenic effects of bevacizumab in advanced non-small-cell-lung cancer patients","display_name":"Dose/dense metronomic chemotherapy with fractioned cisplatin and oral daily etoposide enhances the anti-angiogenic effects of bevacizumab in advanced non-small-cell-lung cancer patients","alternate_titles":[],"publication_year":2010,"publication_date":"2010-05-01","ids":{"openalex":"https://openalex.org/W2011735384","doi":"https://doi.org/10.4161/cbt.9.9.11441","mag":"2011735384","pmid":"https://pubmed.ncbi.nlm.nih.gov/20697196"},"language":"en","primary_location":{"id":"doi:10.4161/cbt.9.9.11441","doi":"https://doi.org/10.4161/cbt.9.9.11441","is_oa":true,"landing_page_url":"https://doi.org/10.4161/cbt.9.9.11441","pdf_url":"https://www.tandfonline.com/doi/pdf/10.4161/cbt.9.9.11441?needAccess=true&role=button","source":{"id":"https://openalex.org/S169029442","display_name":"Cancer Biology & Therapy","issn_l":"1538-4047","issn":["1538-4047","1555-8576"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Biology &amp; Therapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2011735384"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.tandfonline.com/doi/pdf/10.4161/cbt.9.9.11441?needAccess=true&role=button","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021887337","display_name":"Pierpaolo Correale","orcid":"https://orcid.org/0000-0003-2154-6734","observed_orcids":["https://orcid.org/0000-0003-2154-6734"]},"institutions":[{"id":"https://openalex.org/I102064193","display_name":"University of Siena","ror":"https://ror.org/01tevnk56","country_code":"IT","type":"education","lineage":["https://openalex.org/I102064193"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Pierpaolo Correale","raw_affiliation_strings":["Translational Immuno-Oncology Unit, Medical Oncology Section, Department G. Segre of Pharmacology, Siena University School of Medicine, Siena, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Immuno-Oncology Unit, Medical Oncology Section, Department G. Segre of Pharmacology, Siena University School of Medicine, Siena, Italy","institution_ids":["https://openalex.org/I102064193"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044272292","display_name":"Cinzia Remondo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Cinzia Remondo","raw_affiliation_strings":["Translational immuno-Oncology unit ; Medical Oncology Section ; department \"G. Segre\" of Pharmacology ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational immuno-Oncology unit ; Medical Oncology Section ; department \"G. Segre\" of Pharmacology ;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103034032","display_name":"Salvatore Francesco Carbone","orcid":"https://orcid.org/0000-0003-2179-5503","observed_orcids":["https://orcid.org/0000-0003-2179-5503"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Salvatore Francesco Carbone","raw_affiliation_strings":["Radiology Section ; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Radiology Section ; and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073322748","display_name":"Veronica Ricci","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Veronica Ricci","raw_affiliation_strings":["Radiology Section ; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Radiology Section ; and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077306623","display_name":"Cristina Migali","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Cristina Migali","raw_affiliation_strings":["Translational immuno-Oncology unit ; Medical Oncology Section ; department \"G. Segre\" of Pharmacology ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational immuno-Oncology unit ; Medical Oncology Section ; department \"G. Segre\" of Pharmacology ;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080676031","display_name":"Ignazio Martellucci","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ignazio Martellucci","raw_affiliation_strings":["Translational immuno-Oncology unit ; Medical Oncology Section ; department \"G. Segre\" of Pharmacology ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational immuno-Oncology unit ; Medical Oncology Section ; department \"G. Segre\" of Pharmacology ;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055422631","display_name":"Antonella Licchetta","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Antonella Licchetta","raw_affiliation_strings":["Translational immuno-Oncology unit ; Medical Oncology Section ; department \"G. Segre\" of Pharmacology ;","department of Surgery, anesthesiology and Emergency ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational immuno-Oncology unit ; Medical Oncology Section ; department \"G. Segre\" of Pharmacology ;","institution_ids":[]},{"raw_affiliation_string":"department of Surgery, anesthesiology and Emergency ;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087020711","display_name":"Raffaele Addeo","orcid":"https://orcid.org/0000-0001-9197-8060","observed_orcids":["https://orcid.org/0000-0001-9197-8060"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Raffaele Addeo","raw_affiliation_strings":["Oncology department ; \"S. Giovanni di dio\" Hospital ; Frattaminore , naples italy ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology department ; \"S. Giovanni di dio\" Hospital ; Frattaminore , naples italy ;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101925905","display_name":"Luca Volterrani","orcid":"https://orcid.org/0000-0001-9609-116X","observed_orcids":["https://orcid.org/0000-0001-9609-116X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Luca Volterrani","raw_affiliation_strings":["Radiology Section ; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Radiology Section ; and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060465294","display_name":"Giuseppe Gotti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I102064193","display_name":"University of Siena","ror":"https://ror.org/01tevnk56","country_code":"IT","type":"education","lineage":["https://openalex.org/I102064193"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Giuseppe Gotti","raw_affiliation_strings":["Thoracic Surgery Section ; Siena university School of Medicine ; Siena , italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thoracic Surgery Section ; Siena university School of Medicine ; Siena , italy;","institution_ids":["https://openalex.org/I102064193"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110646634","display_name":"Maria Saveria Rotundo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Maria Saveria Rotundo","raw_affiliation_strings":["Medical Oncology unit ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology unit ;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077467836","display_name":"Pierfrancesco Tassone","orcid":"https://orcid.org/0000-0002-8298-6787","observed_orcids":["https://orcid.org/0000-0002-8298-6787"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Pierfrancesco Tassone","raw_affiliation_strings":["Medical Oncology unit ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology unit ;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027280443","display_name":"Pasquale Sperlongano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36443711","display_name":"Magna Graecia University","ror":"https://ror.org/0530bdk91","country_code":"IT","type":"education","lineage":["https://openalex.org/I36443711"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Pasquale Sperlongano","raw_affiliation_strings":["Campus \"Salvatore Venuta\" ; Magna Gr\u00e6cia university and Tommaso Campanella Cancer Center ; Catanzaro , italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Campus \"Salvatore Venuta\" ; Magna Gr\u00e6cia university and Tommaso Campanella Cancer Center ; Catanzaro , italy;","institution_ids":["https://openalex.org/I36443711"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112068633","display_name":"Alberto Abbruzzese","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I197809005","display_name":"University of Campania \"Luigi Vanvitelli\"","ror":"https://ror.org/02kqnpp86","country_code":"IT","type":"education","lineage":["https://openalex.org/I197809005"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alberto Abbruzzese","raw_affiliation_strings":["Second university of naples ; naples , italy","department of Biochemistry and Biophysics ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Second university of naples ; naples , italy","institution_ids":["https://openalex.org/I197809005"]},{"raw_affiliation_string":"department of Biochemistry and Biophysics ;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073891277","display_name":"Michele Caraglia","orcid":"https://orcid.org/0000-0003-2408-6091","observed_orcids":["https://orcid.org/0000-0003-2408-6091"]},"institutions":[{"id":"https://openalex.org/I197809005","display_name":"University of Campania \"Luigi Vanvitelli\"","ror":"https://ror.org/02kqnpp86","country_code":"IT","type":"education","lineage":["https://openalex.org/I197809005"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michele Caraglia","raw_affiliation_strings":["Second university of naples ; naples , italy","department of Biochemistry and Biophysics ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Second university of naples ; naples , italy","institution_ids":["https://openalex.org/I197809005"]},{"raw_affiliation_string":"department of Biochemistry and Biophysics ;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101403092","display_name":"Pierosandro Tagliaferri","orcid":"https://orcid.org/0000-0003-3783-0895","observed_orcids":["https://orcid.org/0000-0003-3783-0895"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Pierosandro Tagliaferri","raw_affiliation_strings":["Medical Oncology unit ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology unit ;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064666635","display_name":"Guido Francini","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Guido Francini","raw_affiliation_strings":["Translational immuno-Oncology unit ; Medical Oncology Section ; department \"G. Segre\" of Pharmacology ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational immuno-Oncology unit ; Medical Oncology Section ; department \"G. Segre\" of Pharmacology ;","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5064666635"],"corresponding_institution_ids":[],"apc_list":{"value":2710,"currency":"EUR","value_usd":2970},"apc_paid":null,"fwci":1.3159,"has_fulltext":true,"cited_by_count":35,"citation_normalized_percentile":{"value":0.77164468,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"9","issue":"9","first_page":"685","last_page":"693"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.7939000129699707,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.7939000129699707,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.121799997985363,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.05389999970793724,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9200000166893005},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9350000023841858},{"id":"https://openalex.org/keywords/metronomic-chemotherapy","display_name":"metronomic chemotherapy","score":0.8759999871253967},{"id":"https://openalex.org/keywords/dose-dense-chemotherapy","display_name":"dose-dense chemotherapy","score":0.7680000066757202},{"id":"https://openalex.org/keywords/oral-etoposide","display_name":"oral etoposide","score":0.9340000152587891},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.9559999704360962},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.921999990940094},{"id":"https://openalex.org/keywords/tumor-perfusion","display_name":"tumor perfusion","score":0.7570000290870667},{"id":"https://openalex.org/keywords/angiopoietin-1","display_name":"angiopoietin-1","score":0.9470000267028809},{"id":"https://openalex.org/keywords/thrombospondin-1","display_name":"thrombospondin-1","score":0.9990000128746033},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.5099999904632568},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.6930000185966492}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.905988872051239},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.8037446737289429},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.6243820786476135},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.5847797393798828},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5564901828765869},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5298504829406738},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.4936562478542328},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.48233839869499207},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4817497730255127},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4409847557544708},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.40228044986724854},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.07872340083122253}],"mesh":[{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D002294","descriptor_name":"Carcinoma, Squamous Cell","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D002294","descriptor_name":"Carcinoma, Squamous Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002294","descriptor_name":"Carcinoma, Squamous Cell","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004797","descriptor_name":"Enzyme-Linked Immunosorbent Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005047","descriptor_name":"Etoposide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019699","descriptor_name":"Thrombospondins","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D020714","descriptor_name":"Maximum Tolerated Dose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D042683","descriptor_name":"Angiopoietin-1","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.4161/cbt.9.9.11441","doi":"https://doi.org/10.4161/cbt.9.9.11441","is_oa":true,"landing_page_url":"https://doi.org/10.4161/cbt.9.9.11441","pdf_url":"https://www.tandfonline.com/doi/pdf/10.4161/cbt.9.9.11441?needAccess=true&role=button","source":{"id":"https://openalex.org/S169029442","display_name":"Cancer Biology & Therapy","issn_l":"1538-4047","issn":["1538-4047","1555-8576"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Biology &amp; Therapy","raw_type":"journal-article"},{"id":"pmid:20697196","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20697196","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer biology & therapy","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:iris.unicampania.it:11591/186967","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11591/186967","pdf_url":null,"source":{"id":"https://openalex.org/S7407055255","display_name":"Archivio Istituzionale della Ricerca - Universit\u00e0 degli Studi della Campania \"Luigi Vanvitelli\"","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:usiena-air.unisi.it:11365/38497","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11365/38497","pdf_url":null,"source":{"id":"https://openalex.org/S4377196319","display_name":"Use Siena air (University of Siena)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I102064193","host_organization_name":"University of Siena","host_organization_lineage":["https://openalex.org/I102064193"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:zenodo.org:128749","doi":null,"is_oa":true,"landing_page_url":"https://www.openaccessrepository.it/record/128749","pdf_url":null,"source":{"id":"https://openalex.org/S4306402478","display_name":"INFM-OAR (INFN Catania)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210116497","host_organization_name":"Istituto Nazionale di Fisica Nucleare, Sezione di Catania","host_organization_lineage":["https://openalex.org/I4210116497"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.4161/cbt.9.9.11441","doi":"https://doi.org/10.4161/cbt.9.9.11441","is_oa":true,"landing_page_url":"https://doi.org/10.4161/cbt.9.9.11441","pdf_url":"https://www.tandfonline.com/doi/pdf/10.4161/cbt.9.9.11441?needAccess=true&role=button","source":{"id":"https://openalex.org/S169029442","display_name":"Cancer Biology & Therapy","issn_l":"1538-4047","issn":["1538-4047","1555-8576"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Biology &amp; Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2011735384.pdf","grobid_xml":"https://content.openalex.org/works/W2011735384.grobid-xml"},"referenced_works_count":31,"referenced_works":["https://openalex.org/W1965122158","https://openalex.org/W1971287424","https://openalex.org/W1973091654","https://openalex.org/W2006202974","https://openalex.org/W2012063336","https://openalex.org/W2034720954","https://openalex.org/W2050775025","https://openalex.org/W2067992759","https://openalex.org/W2069074338","https://openalex.org/W2070439776","https://openalex.org/W2074470232","https://openalex.org/W2079150475","https://openalex.org/W2086062010","https://openalex.org/W2096508282","https://openalex.org/W2100669312","https://openalex.org/W2100785570","https://openalex.org/W2113818241","https://openalex.org/W2114159573","https://openalex.org/W2118177585","https://openalex.org/W2121305414","https://openalex.org/W2125558775","https://openalex.org/W2126275851","https://openalex.org/W2129447971","https://openalex.org/W2137797191","https://openalex.org/W2142052493","https://openalex.org/W2144660856","https://openalex.org/W2145159715","https://openalex.org/W2145835533","https://openalex.org/W2155012968","https://openalex.org/W2158073590","https://openalex.org/W2169965478"],"related_works":["https://openalex.org/W2245346988","https://openalex.org/W2075176584","https://openalex.org/W2058775893","https://openalex.org/W7037579954","https://openalex.org/W2586299539","https://openalex.org/W2600663407","https://openalex.org/W2050790659","https://openalex.org/W2794897677","https://openalex.org/W3093400519","https://openalex.org/W2066135588"],"abstract_inverted_index":{"BACKGROUND:":[0],"We":[1,36],"designed":[2],"a":[3,10,28,50,87,102,170,228],"translational":[4],"clinical":[5],"trial":[6],"to":[7,16,32,104],"investigate":[8],"whether":[9],"dose/dense":[11,229],"chemotherapy":[12,230],"regimen":[13,231],"is":[14],"able":[15],"enhance":[17],"in":[18,53,60,68,181,205],"patients":[19,79,159],"with":[20,101,165,227],"non-small-cell-lung-cancer":[21],"(NSCLC)":[22],"the":[23,33,39,54,69,75,114,182],"anti-angiogenic":[24,238],"effects":[25],"of":[26,42,56,63,71,77,91,106,127,132,173,225],"bevacizumab,":[27],"murine/human":[29],"monoclonal":[30],"antibody":[31],"vasculo-endothelial-growth-factor":[34],"(VEGF).":[35],"also":[37],"evaluated":[38],"antitumor":[40,240],"activity":[41],"this":[43],"combination.":[44],"RESULTS:":[45],"The":[46,141,223],"combined":[47],"treatment":[48],"induced":[49],"significant":[51,237],"decline":[52],"blood-perfusion":[55],"primary":[57],"tumor":[58],"(NMR-study);":[59],"serum":[61],"levels":[62],"VEGF,":[64],"angiopoietin-1,":[65],"thrombospondin-1;":[66],"and":[67,86,96,129,145,151,162,176,195,202,216,239],"number":[70],"VEGF-transporting":[72],"cells.":[73],"In":[74],"group":[76],"40":[78],"who":[80],"received":[81,185],"bevacizumab":[82,137,210,226],"an":[83],"objective":[84],"response":[85],"disease":[88],"stabilization":[89],"rate":[90],"77.5%":[92],"(95%":[93],"CI,":[94],"75.63-93.17)":[95],"15%,":[97],"respectively,":[98],"were":[99,139,149,179,203],"recorded":[100],"time":[103],"progression":[105],"7.6":[107],"mo.":[108],"Grade":[109],"I-II":[110],"hematological":[111],"toxicity":[112],"was":[113],"most":[115,142],"common":[116],"adverse":[117],"event.":[118],"Four":[119],"early":[120],"deaths":[121],"within":[122],"3":[123,187],"mo,":[124],"three":[125],"cases":[126,131],"pneumonia,":[128],"six":[130,163],"mood":[133],"depression":[134],"at":[135],"higher":[136],"dosage":[138],"observed.":[140],"active":[143],"biological":[144],"maximum":[146],"tolerated":[147],"dose":[148],"5":[150],"7.5":[152],"mg/kg,":[153],"respectively.":[154],"PATIENTS":[155],"AND":[156],"METHODS:":[157],"Forty-eight":[158],"(42":[160],"males":[161],"females)":[164],"stage":[166],"III":[167],"B/IV":[168],"NSCLC,":[169],"mean":[171],"age":[172],"68":[174],"y,":[175],"ECOG":[177],"<or=2":[178],"enrolled":[180],"study.":[183],"They":[184],"every":[186],"w":[188],"fractioned":[189],"cisplatinum":[190],"(30":[191],"mg/sqm,":[192],"days":[193,200],"1-3)":[194],"oral":[196],"etoposide":[197],"(50":[198],"mg,":[199],"1-15)":[201],"divided":[204],"five":[206],"cohorts":[207],"receiving":[208],"different":[209],"dosages":[211],"(0;":[212],"2.5;":[213],"5;":[214],"7.5;":[215],"10":[217],"mg/kg)":[218],"on":[219],"day":[220],"3.":[221],"CONCLUSION:":[222],"combination":[224],"resulted":[232],"moderately":[233],"safe":[234],"but":[235],"showed":[236],"activity.":[241]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2011735384","counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2016-06-24T00:00:00"}
